{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:23:16Z","timestamp":1787167396153,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.bmc.2021.116195","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T22:51:57Z","timestamp":1620168717000},"page":"116195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Design, synthesis and anti-HIV evaluation of novel 5-substituted diarylpyrimidine derivatives as potent HIV-1 NNRTIs"],"prefix":"10.1016","volume":"40","author":[{"given":"Ping","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Pannecouque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"De Clercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2021.116195_b0005","doi-asserted-by":"crossref","unstructured":"R.J. Shattock, M. Warren, S. McCormack, C.A. Hankins, AIDS. Turning the tide against HIV, Science, 333 (2011) 42-43.","DOI":"10.1126\/science.1206399"},{"key":"10.1016\/j.bmc.2021.116195_b0010","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.apsb.2015.09.001","article-title":"An Odyssey in antiviral drug development-50 years at the Rega Institute: 1964\u20132014","volume":"5","author":"De Clercq","year":"2015","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmc.2021.116195_b0015","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/nrmicro3132","article-title":"Past, present and future: 30 years of HIV research","volume":"11","author":"Barr\u00e9-Sinoussi","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bmc.2021.116195_b0020","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1021\/acs.jmedchem.8b00843","article-title":"The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic","volume":"62","author":"Namasivayam","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116195_b0025","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMp1710608","article-title":"HIV Drug Resistance - An Emerging Threat to Epidemic Control","volume":"377","author":"Beyrer","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2021.116195_b0030","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.apsb.2019.08.013","article-title":"Exploring the hydrophobic channel of NNIBP leads to the discovery of novel piperidine-substituted thiophene[3,2-d]pyrimidine derivatives as potent HIV-1 NNRTIs","volume":"10","author":"Kang","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmc.2021.116195_b0035","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.apsb.2019.08.009","article-title":"Synthesis and biological evaluation of a series of 2-(((5-akly\/aryl-1H-pyrazol-3-yl)methyl)thio)-5-alkyl-6-(cyclohexylmethyl)-pyrimidin-4(3H)-ones as potential HIV-1 inhibitors","volume":"10","author":"Wu","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmc.2021.116195_b0040","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.bmc.2014.02.029","article-title":"Fused heterocyclic compounds bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 1: design, synthesis and biological evaluation of novel 5,7-disubstituted pyrazolo[1,5-a]pyrimidine derivatives","volume":"22","author":"Tian","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2021.116195_b0045","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ejmech.2014.07.104","article-title":"Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 2: discovery of novel [1,2,4]Triazolo[1,5-a]pyrimidines using a structure-guided core-refining approach","volume":"85","author":"Wang","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2021.116195_b0050","unstructured":"J. Girardet, H. Zhi, S. Stephanie, K. Yung-Hyo, Cyanophenylamino-substituted thienopyrimidine compounds as non-nucleoside reverse transcriptase inhibitors, their preparation, pharmaceutical compositions, and use as anti-HIV treatment, PCT Int. Appl. (2008), WO 2008058285 A2 20080515."},{"key":"10.1016\/j.bmc.2021.116195_b0055","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.cclet.2020.03.028","article-title":"New techniques and strategies in drug discovery","volume":"31","author":"Du","year":"2020","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.bmc.2021.116195_b0060","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1021\/acsmedchemlett.7b00524","article-title":"Discovery of Novel Diarylpyrimidine Derivatives as Potent HIV-1 NNRTIs Targeting the \u201cNNRTI Adjacent\u201d Binding Site","volume":"9","author":"Huo","year":"2018","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2021.116195_b0065","unstructured":"URL: http:\/\/www.certara.com\/products\/molmod\/surflex\/surflex-dock\/."},{"key":"10.1016\/j.bmc.2021.116195_b0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0166-0934(88)90134-6","article-title":"Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds","volume":"20","author":"Pauwels","year":"1988","journal-title":"J Virol Methods"},{"key":"10.1016\/j.bmc.2021.116195_b0075","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nprot.2007.517","article-title":"Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later","volume":"3","author":"Pannecouque","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.bmc.2021.116195_b0080","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.6200935","article-title":"Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS","volume":"224","author":"Popovic","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.bmc.2021.116195_b0085","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1126\/science.2425430","article-title":"Isolation of a new Human Retrovirus from West African Patients with AIDS","volume":"233","author":"Clavel","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.bmc.2021.116195_b0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0166-0934(93)90054-U","article-title":"Poly A-linked colorimetric microtiter plate assay for HIV reverse transcriptase","volume":"44","author":"Suzuki","year":"1993","journal-title":"J Virol Methods"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621002030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621002030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:14:34Z","timestamp":1760836474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089621002030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":18,"alternative-id":["S0968089621002030"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116195","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and anti-HIV evaluation of novel 5-substituted diarylpyrimidine derivatives as potent HIV-1 NNRTIs","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116195","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116195"}}